Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

<< Previous
Bullboard Posts
Next >>
Post by bossuon Apr 12, 2023 5:21pm
180 Views
Post# 35391622

Car count steady...

Car count steady...What I said 2 weeks ago..
''So 80 cars mean $ 10 M in top line revenue and 125 cars mean a $ 15,6  M revenue in a quarter .
As long as the parking is at a 60 % capacity top line revenu is going to ''linger'' for sometimes ! ''
Bearish trading patern lately ...and share price probably going to drift for sometimes unless Mr Laflamme elaborate on the number of ''
SAVVYWIRE PROCEDURE'' to be used by physicians  on a quarterly basis  taking for granted the 1000 mark announced on April 5 2023.
The ''early commercialization phase'' is progressing but operating cost in the Q1 2023 was $ 9,7 M compared to $ 6,0 M in the Q1 2022 and probably be higher in the Q2 2023.

It's now the time to deliver on ''guidance'' for the number of procedures per quarter starting from April 1 2023 and forecast procedures for the next 3 months and so on .




<< Previous
Bullboard Posts
Next >>